© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Kestra Medical Technologies, Ltd. (KMTS) stock surged +5.30%, trading at $24.06 on NASDAQ, up from the previous close of $22.85. The stock opened at $22.87, fluctuating between $22.87 and $24.43 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 22.87 | 24.43 | 22.80 | 24.06 | 739.82K |
| Sep 11, 2026 | 23.91 | 24.38 | 22.44 | 22.85 | 241.58K |
| Sep 10, 2026 | 23.45 | 24.43 | 23.25 | 23.57 | 310.5K |
| Sep 09, 2026 | 25.32 | 25.57 | 24.03 | 24.07 | 303.11K |
| Sep 08, 2026 | 25.45 | 25.83 | 24.87 | 25.64 | 349.34K |
| Sep 04, 2026 | 25.01 | 25.67 | 24.76 | 25.54 | 181.78K |
| Sep 03, 2026 | 26.14 | 26.14 | 24.82 | 25.14 | 200.38K |
| Sep 02, 2026 | 25.46 | 26.50 | 25.10 | 25.73 | 245.54K |
| Sep 01, 2026 | 25.54 | 26.19 | 25.05 | 25.12 | 319.32K |
| Aug 31, 2026 | 25.38 | 25.90 | 25.06 | 25.75 | 351.3K |
| Aug 28, 2026 | 25.60 | 26.28 | 25.49 | 25.64 | 151.43K |
| Aug 27, 2026 | 26.56 | 27.24 | 25.78 | 25.81 | 198.31K |
| Aug 26, 2026 | 26.64 | 26.99 | 26.07 | 26.57 | 210.74K |
| Aug 25, 2026 | 27.24 | 27.50 | 26.49 | 26.92 | 159.55K |
| Aug 24, 2026 | 26.98 | 27.53 | 26.24 | 26.91 | 171.36K |
| Aug 21, 2026 | 27.41 | 27.46 | 26.31 | 26.99 | 510.79K |
| Aug 20, 2026 | 27.49 | 28.11 | 27.00 | 27.26 | 246.91K |
| Aug 19, 2026 | 28.31 | 28.89 | 27.66 | 27.91 | 237.65K |
| Aug 18, 2026 | 27.55 | 28.33 | 26.69 | 27.93 | 249.11K |
| Aug 17, 2026 | 27.52 | 28.02 | 26.90 | 27.82 | 193.75K |
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
| Employees | 443 |
| Beta | 0.62 |
| Sales or Revenue | $95.13M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | April |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |